FDA Publishes Guidance on Microbiology Data for Antibacterial Drugs

Drug Industry Daily
A A
Sponsors of systemic antibacterial drugs should evaluate their products against test panels of relevant bacteria and against approved drugs with similar mechanisms of activity, the FDA said, in a newly revised guidance.

To View This Article:

Login

Subscribe To Drug Industry Daily